Kim Jane Paik, Tsungmey Tenzin, Rostami Maryam, Mondal Sangeeta, Kasun Max, Roberts Laura Weiss
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine.
Ethics Behav. 2022;32(7):601-617. doi: 10.1080/10508422.2021.1957678. Epub 2021 Sep 22.
Little is known about how individuals with and without mood disorders perceive the inherent risks and helpfulness of participating in innovative psychiatric research, or about the factors that influence their willingness to participate. We conducted an online survey with 80 individuals (self-reported mood disorder [n = 25], self-reported good health [n = 55]) recruited via MTurk. We assessed respondents' perceptions of risk and helpfulness in study vignettes associated with two innovative research projects (intravenous ketamine therapy and wearable devices), as well as their willingness to participate in these projects. Respondents with and without mood disorders perceived risk similarly across projects. Respondents with no mood disorders viewed both projects as more helpful to society than to research volunteers, while respondents with mood disorders viewed the projects as equally helpful to volunteers and society. Individuals with mood disorders perceived ketamine research, and the two projects on average, as more helpful to research volunteers than did individuals without mood disorders. Our findings add to a limited empirical literature on the perspectives of volunteers in innovative psychiatric research.
对于患有和未患有情绪障碍的个体如何看待参与创新性精神科研究的内在风险和益处,以及影响他们参与意愿的因素,我们所知甚少。我们通过亚马逊土耳其机器人(MTurk)招募了80名个体(自我报告患有情绪障碍的有25人,自我报告健康状况良好的有55人)进行了一项在线调查。我们评估了受访者对与两个创新性研究项目(静脉注射氯胺酮疗法和可穿戴设备)相关的研究 vignettes 中的风险和益处的看法,以及他们参与这些项目的意愿。患有和未患有情绪障碍的受访者在各个项目中对风险的认知相似。没有情绪障碍的受访者认为这两个项目对社会的帮助大于对研究志愿者的帮助,而患有情绪障碍的受访者则认为这些项目对志愿者和社会的帮助相同。患有情绪障碍的个体认为氯胺酮研究以及这两个项目平均而言对研究志愿者的帮助比没有情绪障碍的个体更大。我们的研究结果为关于创新性精神科研究中志愿者观点的有限实证文献增添了内容。